Drugs / SHED-CM
SHED-CM
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT06889857 | Apr 2024 → Dec 2026 expected | amyotrophic lateral sclerosis | Hitonowa Medical | Active not recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SHED-CM | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06889857 ↗ |
| Known as | Stem Cell from Human Exfoliated Deciduous teeth Conditioned Media | “This study evaluates the safety and efficacy of Stem Cell from Human Exfoliated Deciduous teeth Conditioned Media (SHED-CM) in patients with Amyotrophic Lateral Sclerosis...” NCT06889857 ↗ |
| Route | Intravenous | “The study drug will be administered intravenously at 120 ml once a week for 12 week.” NCT06889857 ↗ |